Results 291 to 300 of about 651,238 (350)
Some of the next articles are maybe not open access.

Related searches:

Liver cirrhosis

Lancet, The, 2021
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload.
Aleksander Krag   +2 more
exaly   +5 more sources

Liver cirrhosis

Lancet, The, 2014
Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death worldwide but fourth in central Europe. Increasingly, cirrhosis has been seen to be not a single disease entity, but one that can be subclassified into distinct clinical prognostic stages, with 1-year mortality ranging from
Jaime Bosch, Andrew K Burroughs
exaly   +3 more sources

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Lancet, The, 2019
BACKGROUND Clinical decompensation of cirrhosis is associated with poor prognosis. Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure gradient (HVPG) ≥10 mm Hg, is the strongest predictor of decompensation. This study
Candid Villanueva   +2 more
exaly   +2 more sources

Cirrhosis-associated immune dysfunction

Nature Reviews Gastroenterology and Hepatology, 2021
Agustín Albillos   +2 more
exaly   +2 more sources

Laennec's Cirrhosis

The American Journal of Nursing, 1965
T.aennec named the firm, diffusely fibrotic liver with its orange-colored projecting nodules "cirrhosis," after the Greek word kirrhos, meaning orange. Other synonyms are portal cirrhosis, alcoholic (ethanolic) cirrhosis, fatty cirrhosis, atrophic cirrhosis, and "gin drinker's liver." Laennec's cirrhosis is a pathologic entity in which a varying degree
M T, BIELSKI, D W, MOLANDER
openaire   +2 more sources

Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials.

Journal of Hepatology, 2020
BACKGROUND & AIMS Apoptosis signal-regulating kinase 1 (ASK1) plays a key role in hepatocyte injury, inflammation, and fibrosis in nonalcoholic steatohepatitis (NASH). We evaluated the safety and anti-fibrotic effect of selonsertib, a selective inhibitor
Stephen A. Harrison   +26 more
semanticscholar   +1 more source

Familial Cirrhosis

Archives of Pediatrics & Adolescent Medicine, 1979
Three pairs of siblings with cirrhosis were investigated. The histopathological examination of the liver biopsy specimens and the laboratory findings did not give any clue about the cause of the disease. The presence of familial cirrhosis was considered.
N, Koçak, S, Ozsoylu
openaire   +2 more sources

Home - About - Disclaimer - Privacy